Purpose: To prove the feasibility of arterial spin labeling (ASL) to explore brain tumors by comparing dynamic susceptibility contrast-enhanced MRI to ASL at 3T MR. Materials and Methods: Twenty-seven patients were included presenting 9 gliomas, 10 metastases and 8 meningiomas. All were explored by a pseudo-continuous ASL and dynamic susceptibility contrast-enhanced T2* perfusion sequence. Two neuroradiologists analyzed the cerebral blood flow (CBF) maps to assess feasibility, examination quality and quantitative comparison. The Spearman nonparametric correlation test and the Bland-Altman graphic test were used to analyze our quantitative results. Results: 92% of ASL CBF maps were informative. ASL detected all lesions as well as dynamic susceptibility contrast-enhanced MRI. Both sequences provide relative quantitative CBF values closely correlated. Conclusion: On a 3T MR unit, ASL is a good alternative to dynamic susceptibility contrast-enhanced MRI when contrast medium is contraindicated or intravenous injection is not possible. Its results on relative CBF parameters are similar to contrast-injected perfusion.

Keywords:
Arterial spin labeling, Perfusion, Cerebral blood flow, Cerebral neoplasm, 3T MR
1.
Folkerth RD: Descriptive analysis and quantification of angiogenesis in human brain tumors. J Neuro-oncol 2000;50:165–172.
2.
Kleihues P, Louis DN, Scheithauer BW, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215–225; discussion 226–219.
3.
Giese A, Westphal M: Treatment of malignant glioma: a problem beyond the margins of resection. J Cancer Res Clin Oncol 2001;127:217–225.
4.
Law M, Young RJ, Babb JS, et al: Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247:490–498.
5.
Schiff D: Single brain metastasis. Curr Treat Options Neurol 2001;3:89–99.
6.
Wiginton CD, Kelly B, Oto A, et al: Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR Am J Roentgenol 2008;190:1060–1068.
7.
Golay X, Petersen ET: Arterial spin labeling: benefits and pitfalls of high magnetic field. Neuroimaging Clin N Am 2006;16:259–268.
8.
Wang J, Alsop DC, Li L, et al: Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med 2002;48:242–254.
9.
Knopp EA, Cha S, Johnson G, et al: Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–798.
10.
Detre JA, Leigh JS, Williams DS, Koretsky AP: Perfusion imaging. Magn Reson Med 1992;23:37–45.
11.
Williams DS, Detre JA, Leigh JS, Koretsky AP: Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 1992;89:212–216.
12.
Edelman RR, Siewert B, Darby DG, et al: Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency. Radiology 1994;192:513–520.
13.
Kim SG: Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med 1995;34:293–301.
14.
Wu WC, Fernandez-Seara M, Detre JA, Wehrli FW, Wang J: A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med 2007;58:1020–1027.
15.
Dai W, Garcia D, de Bazelaire C, Alsop DC: Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60:1488–1497.
16.
Garcia DM, De Bazelaire C, Alsop DC: Pseudo-continuous Flow Driven Adiabatic Inversion for Arterial Spin Labeling. Miami, ISMRM, 2005.
17.
Warmuth C, Gunther M, Zimmer C: Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 2003;228:523–532.
18.
Kimura H, Takeuchi H, Koshimoto Y, et al: Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features. AJNR Am J Neuroradiol 2006;27:85–93.
19.
Weber MA, Zoubaa S, Schlieter M, et al: Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 2006;66:1899–1906.
20.
Ludemann L, Warmuth C, Plotkin M, et al: Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. Eur J Radiol 2009;70:465–474.
21.
Weber MA, Gunther M, Lichy MP, et al: Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue. Invest Radiol 2003;38:712–718.
22.
Jarnum H, Steffensen EG, Knutsson L, et al: Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology 2010;52:307–317.
23.
Kim MJ, Kim HS, Kim JH, Cho KG, Kim SY: Diagnostic accuracy and interobserver variability of pulsed arterial spin labeling for glioma grading. Acta Radiol 2008;49:450–457.
24.
Tourdias T, Rodrigo S, Oppenheim C, et al: Pulsed arterial spin labeling applications in brain tumors: practical review. J Neuroradiol 2008;35:79–89.
25.
Wolf RL, Wang J, Wang S, et al: Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla. J Magn Reson Imaging 2005;22:475–482.
26.
Wang J, Fernandez-Seara MA, Wang S, St Lawrence KS: When perfusion meets diffusion: in vivo measurement of water permeability in human brain. J Cereb Blood Flow Metab 2007;27:839–849.
27.
Petersen ET, Lim T, Golay X: Model-free arterial spin labeling quantification approach for perfusion MRI. Magn Reson Med 2006;55:219–232.
28.
Wang J, Alsop DC, Song HK, et al: Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med 2003;50:599–607.
29.
Gunther M, Bock M, Schad LR: Arterial spin labeling in combination with a look-locker sampling strategy: inflow turbo-sampling EPI-FAIR (ITS-FAIR). Magn Reson Med 2001;46:974–984.
30.
Ye FQ, Berman KF, Ellmore T, et al: H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med 2000;44:450–456.
31.
Parkes LM, Rashid W, Chard DT, Tofts PS: Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects. Magn Reson Med 2004;51:736–743.
32.
Alsop DC, Detre JA: Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998;208:410–416.
33.
Silva AC, Zhang W, Williams DS, Koretsky AP: Multi-slice MRI of rat brain perfusion during amphetamine stimulation using arterial spin labeling. Magn Reson Med 1995;33:209–214.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.